| Histology—no. (%) . | |
|---|---|
| Clear cell Unclassified Papillary . | 19 (79%) 4 (17%) 1 (4%) . |
| AJCC pathologic T—no. (%) pT0 pT1 pT2 pT3 pT4 | 5 (21%) 3 (12%) 4 (17%) 10 (42%) 2 (8%) |
| Pathological Nodal Involvement—no. (%) Yes (N1) No (N0) Not assessed (Nx) | 3 (12%) 9 (38%) 12 (50%) |
| Presence of Sarcomatoid differentiation—no. (%) Yes | 3 (12%) |
| Fuhrman Grade—no. (%) 1 2 3 4 Not reported | 0 (0%) 3 (12%) 7 (29%) 10 (42%) 4 (17%) |
| Presence of necrosis—no. (%) Yes No | 23 (96%) 1 (4%) |
| Extension of necrosis—no. (%) ≥95% <95% | 10 (42%) 14 (58%) |
| Histology—no. (%) . | |
|---|---|
| Clear cell Unclassified Papillary . | 19 (79%) 4 (17%) 1 (4%) . |
| AJCC pathologic T—no. (%) pT0 pT1 pT2 pT3 pT4 | 5 (21%) 3 (12%) 4 (17%) 10 (42%) 2 (8%) |
| Pathological Nodal Involvement—no. (%) Yes (N1) No (N0) Not assessed (Nx) | 3 (12%) 9 (38%) 12 (50%) |
| Presence of Sarcomatoid differentiation—no. (%) Yes | 3 (12%) |
| Fuhrman Grade—no. (%) 1 2 3 4 Not reported | 0 (0%) 3 (12%) 7 (29%) 10 (42%) 4 (17%) |
| Presence of necrosis—no. (%) Yes No | 23 (96%) 1 (4%) |
| Extension of necrosis—no. (%) ≥95% <95% | 10 (42%) 14 (58%) |
| Histology—no. (%) . | |
|---|---|
| Clear cell Unclassified Papillary . | 19 (79%) 4 (17%) 1 (4%) . |
| AJCC pathologic T—no. (%) pT0 pT1 pT2 pT3 pT4 | 5 (21%) 3 (12%) 4 (17%) 10 (42%) 2 (8%) |
| Pathological Nodal Involvement—no. (%) Yes (N1) No (N0) Not assessed (Nx) | 3 (12%) 9 (38%) 12 (50%) |
| Presence of Sarcomatoid differentiation—no. (%) Yes | 3 (12%) |
| Fuhrman Grade—no. (%) 1 2 3 4 Not reported | 0 (0%) 3 (12%) 7 (29%) 10 (42%) 4 (17%) |
| Presence of necrosis—no. (%) Yes No | 23 (96%) 1 (4%) |
| Extension of necrosis—no. (%) ≥95% <95% | 10 (42%) 14 (58%) |
| Histology—no. (%) . | |
|---|---|
| Clear cell Unclassified Papillary . | 19 (79%) 4 (17%) 1 (4%) . |
| AJCC pathologic T—no. (%) pT0 pT1 pT2 pT3 pT4 | 5 (21%) 3 (12%) 4 (17%) 10 (42%) 2 (8%) |
| Pathological Nodal Involvement—no. (%) Yes (N1) No (N0) Not assessed (Nx) | 3 (12%) 9 (38%) 12 (50%) |
| Presence of Sarcomatoid differentiation—no. (%) Yes | 3 (12%) |
| Fuhrman Grade—no. (%) 1 2 3 4 Not reported | 0 (0%) 3 (12%) 7 (29%) 10 (42%) 4 (17%) |
| Presence of necrosis—no. (%) Yes No | 23 (96%) 1 (4%) |
| Extension of necrosis—no. (%) ≥95% <95% | 10 (42%) 14 (58%) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
